| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $65.46M | - | |
| VP | 66.5K | $32.61M | - | |
| VP | 51.1K | $25.05M | - | |
| VP | 42.3K | $20.74M | - | |
| Other | 24.0K | $11.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,651 | $351.00 | $1,983,501.00 | -9.8% | +12.9% | +32.4% | |
| Sep 5, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,651 | $352.66 | $1,992,881.66 | -8.9% | +0.7% | +37.4% | |
| Aug 23, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 2,500 | $355.00 | $887,500.00 | -4.9% | +1.2% | +36.9% | |
| Aug 10, 2023 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 10,031 | $350.00 | $3,510,850.00 | -14.6% | +8.5% | +34.9% | |
| Aug 10, 2023 | Kearney Terrence C | Director | Sale+OE | 10,000 | $350.00 | $3,500,000.00 | -60.5% | +8.5% | +34.9% | |
| Aug 10, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 5,750 | $345.79 | $1,988,292.50 | -10.1% | +8.5% | +34.9% | |
| Aug 9, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 63 | $345.51 | $21,767.13 | -0.2% | +9.6% | +35.0% | |
| Aug 9, 2023 | Bhatia Sangeeta N.48 | Director | Sell | 242 | $345.51 | $83,613.42 | -5.2% | +9.6% | +35.0% | |
| Jul 17, 2023 | Kewalramani Reshma55 | CEO &President | Sell | 7,828 | $355.00 | $2,778,940.00 | -6.2% | +4.5% | +36.6% | |
| Jul 17, 2023 | Sachs Bruce I51 | Director | Sale+OE | 11,250 | $356.75 | $4,013,458.81 | -7.8% | +4.5% | +36.6% |